U.S. flag

An official website of the United States government

NM_000435.3(NOTCH3):c.1630C>T (p.Arg544Cys) AND Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 23, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001805784.9

Allele description [Variation Report for NM_000435.3(NOTCH3):c.1630C>T (p.Arg544Cys)]

NM_000435.3(NOTCH3):c.1630C>T (p.Arg544Cys)

Gene:
NOTCH3:notch receptor 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.12
Genomic location:
Preferred name:
NM_000435.3(NOTCH3):c.1630C>T (p.Arg544Cys)
Other names:
Chinese founder variant; p.Arg544Cys
HGVS:
  • NC_000019.10:g.15187315G>A
  • NG_009819.1:g.18667C>T
  • NM_000435.3:c.1630C>TMANE SELECT
  • NP_000426.2:p.Arg544Cys
  • NC_000019.9:g.15298126G>A
  • NM_000435.2:c.1630C>T
Protein change:
R544C
Links:
dbSNP: rs201118034
NCBI 1000 Genomes Browser:
rs201118034
Molecular consequence:
  • NM_000435.3:c.1630C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Synonyms:
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy; CASIL
Identifiers:
MONDO: MONDO:0007432; MedGen: C0751587; OMIM: PS125310

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002051334Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Dec 23, 2021)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation.

Kim Y, Choi EJ, Choi CG, Kim G, Choi JH, Yoo HW, Kim JS.

Neurology. 2006 May 23;66(10):1511-6.

PubMed [citation]
PMID:
16717210

Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles.

Liao YC, Hsiao CT, Fuh JL, Chern CM, Lee WJ, Guo YC, Wang SJ, Lee IH, Liu YT, Wang YF, Chang FC, Chang MH, Soong BW, Lee YC.

PLoS One. 2015;10(8):e0136501. doi: 10.1371/journal.pone.0136501.

PubMed [citation]
PMID:
26308724
PMCID:
PMC4550240
See all PubMed Citations (5)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002051334.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

Variant summary: NOTCH3 c.1630C>T (p.Arg544Cys) results in a non-conservative amino acid change at a location bordered between the EGFR-13 and EGFR-14 domains (IPR000742) of the encoded protein sequence. This is different from other cysteine involving mutations residing within an EGFR domain and therefore, comparing with other cysteine-involving NOTCH3 mutations, R544C may result in a milder conformational change of NOTCH3 molecules and consequently a milder clinical phenotype (Liao_2015). Gain/loss of cysteine residues in the EGFr domains in NOTCH3 have been shown to be typical mutations of CADASIL and NOTCH3-related disorders (reviewed by Mizuno_2020). Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00032 in 250312 control chromosomes, particularly at a frequency of 0.0041 within the East Asian subpopulation in the gnomAD database. c.1630C>T has been reported in the literature in multiple individuals/families (mainly of East Asian origin) affected with CADASIL and NOTCH3-Related Disorders (example: Oberstein_1999, Kim_2006, Soong_2013, Liao_2015). Asymptomatic individuals with the variant have also been reported within affected families (example: Kim_2006, Liao_2015). Recent data suggest that CADASIL is much more prevalent than previously suspected and the NOTCH3 clinical spectrum must be considerably broader, ranging from classic CADASIL to a much milder small-vessel disease, or possibly even non-penetrance (Hack RJ, Rutten J, Lesnik Oberstein SAJ. CADASIL. 2000 Mar 15 [Updated 2019 Mar 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Seven ClinVar submitters have assessed this variant since 2014: four have classified the variant as likely pathogenic and three as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 8, 2025